NCT01830933

Brief Summary

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,235

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Jun 2011

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 12, 2013

Completed
1 month until next milestone

Results Posted

Study results publicly available

May 16, 2013

Completed
Last Updated

August 19, 2014

Status Verified

August 1, 2014

Enrollment Period

1.2 years

First QC Date

April 10, 2013

Results QC Date

May 15, 2013

Last Update Submit

August 14, 2014

Conditions

Keywords

Breast cancer concern, breast cancer risk perception, breast cancer risk

Outcome Measures

Primary Outcomes (4)

  • Knowledge of Breast Cancer Risk Factors

    Risk knowledge was assessed using a post-survey. Participants could have scored 0-100 (with 0 meaning no correct answers, and 100 is all correct answers). This outcome was measured through a survey. Breast cancer risk knowledge was based on a series of eight questions in the survey. O

    one week post-initial visit (approximately one week)

  • Percentage of Participants With Correct Perception of Risk

    This outcome was measured through a survey. Women were asked what they thought about their risk of getting breast cancer was compared to other women of the same age.

    baseline, one week post-initial visit (approximately one week)

  • Percentage of Participants Who Had a Discussion of Breast Cancer Risk

    Self-reported discussion of breast cancer risk with physicians.

    one week post-initial visit (approximately one week)

  • Percentage of Participants Who Reported Discussion of Mammography Screening

    Self reported discussion of mammography with physician.

    up to 14 months

Study Arms (2)

BreastCARE Intervention

EXPERIMENTAL

Intervention Clinic Patients: The RA will welcome the patient upon arrival at the clinic and again explain study procedures and field any questions. The RA will have the patient sign the HIPAA authorization form and then demonstrate how to enter information and answer questions on the tablet-PC and the patient will indicate their consent electronically before beginning the assessment. Intervention Patient Report. Once the patient completes the BreastCare Computer survey, the program will immediately generate a personal feedback report containing information about her risk factors and recommendations to reduce her risk. This report will be printed and given to the patietns before she meets with her doctor.

Other: BreastCARE

BreastCARE Comparison

NO INTERVENTION

Patients will be randomized into the intervention or comparison groups at the time of recruitment. Block-randomization will be used to assign patients to intervention or comparison groups. Comparison Clinic Patients. Contact and baseline interview procedures will be the same for patients from the comparison clinics, however there will be no computer assessment at the time of their clinic visit. An RA will meet the patient 10 minutes prior to her appointment time to obtain written HIPAA authorization.

Interventions

Physician Report. At the time of an individual participant's visit to her primary care physician and her completion of the assessment tool, her physician will receive a physician report. The physician report is designed to facilitate communication about breast cancer risk during the primary care visit and to provide tailored risk reduction recommendations.

BreastCARE Intervention

Eligibility Criteria

Age40 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient component:
  • Women who visit the General Internal Medicine (GIM) practices at SFGH and UCSF during the study period
  • Between the ages of 40 and 74
  • Self-identify as Asian American, Spanish- and English-speaking Latinas, African American, or White
  • Have no history of breast cancer are eligible to participate.
  • Physician component: Primary care physicians currently practicing at the GIM clinics at SFGH and UCSF

You may not qualify if:

  • Patient component: Women whose physicians object to their participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

San Francisco General Hospital (SFGH)

San Francisco, California, 94110, United States

Location

University of California, San Francisco Mt. Zion campus

San Francisco, California, 94143, United States

Location

Related Publications (1)

  • Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Perez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Dec;24(6):758-66. doi: 10.1016/j.breast.2015.09.009. Epub 2015 Oct 21.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Results Point of Contact

Title
Celia P. Kaplan, Professor
Organization
University of California, San Francisco

Study Officials

  • Celia P Kaplan, DrPH, MA

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2013

First Posted

April 12, 2013

Study Start

June 1, 2011

Primary Completion

August 1, 2012

Study Completion

December 1, 2012

Last Updated

August 19, 2014

Results First Posted

May 16, 2013

Record last verified: 2014-08

Locations